Family genetics evaluations. Several family visits with the geneticist and subsequent laboratory evaluations revealed that Bobby had PWS. It was also established that his siblings did not have the ...

Results Show Improvement in Multiple Behavioral Domains Following Treatment with DCCR Data Presented in a Poster at the Pediatric Academic Societies Annual Meeting REDWOOD CITY, Calif., May 04, 2021 ...

(Reuters) -The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic disorder, making it the first treatment available for patients who experience ...

Learn about Prader-Willi Syndrome—its causes, symptoms, diagnosis, and treatment options—to support individuals and improve ...

Pitolisant is currently marketed under the brand name Wakix and is approved to treat EDS or cataplexy in adults with narcolepsy. The Food and Drug Administration (FDA) has granted Orphan Drug ...

Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder caused by an abnormality in the gene expression on chromosome 15. The Prader-Willi Syndrome Association USA estimates that PWS ...

WOODBRIDGE, Va. (DC News Now) — May 15 marks National Prader-Willi Syndrome Awareness Day. For one Virginia father, the date is more than just a spot on the calendar — it’s a call to action. Charles ...

REDWOOD CITY, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, ...

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) released topline results on Wednesday from its Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin (ACP-101) in patients ...

HOW TO TAKE THE POST-TEST: Click here after reading the article to take the post-test on myCME.com. Approximately 17% of children and adolescents in the United States are overweight or obese, which ...